Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study

OBJECTIVE: Type B insulin resistance due to autoantibodies against the insulin receptor is characterized by diabetes refractory to massive doses of insulin, severe hypercatabolism, hyperandrogenism, and a high mortality rate. We analyzed the efficacy of combined immunosuppressive therapy in the mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Klubo-Gwiezdzinska, Joanna, Lange, Maria, Cochran, Elaine, Semple, Robert K., Gewert, Cornelia, Brown, Rebecca J., Gorden, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196834/
https://www.ncbi.nlm.nih.gov/pubmed/30201849
http://dx.doi.org/10.2337/dc18-0884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196834/
https://www.ncbi.nlm.nih.gov/pubmed/30201849
http://dx.doi.org/10.2337/dc18-0884

Ejemplares similares